Abeona Therapeutics(ABEO)

chuminhua04-23 11:46

4/22，Abeona Therapeutics $Abeona Therapeutics(ABEO)$ 表示，其针对隐性营养不良性大疱性表皮松解症 (DEB) 患者的自体基因校正细胞疗法 prademagene zamikeracel (pz-cel) 收到了 FDA 的完整回复信 (CRL)。 该公司股价周一盘后交易中暴跌 51%。
FDA 表示，Abeona 必须满足额外的CMC 要求才...查看全文

持股变动声明

Abeona Therapeutics(ABEO)06-21 04:35

$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-024527  Size: 5 KB 网页链接查看全文

持股变动声明

Abeona Therapeutics(ABEO)06-08 04:35

$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-023117  Size: 5 KB 网页链接查看全文

持股变动声明

Abeona Therapeutics(ABEO)06-08 04:35

$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-023122  Size: 5 KB 网页链接查看全文

增发股票注册声明

Abeona Therapeutics(ABEO)06-12 19:05

$Abeona Therapeutics(ABEO)$ S-3 Registration statement under Securities Act of 1933 Accession Number: 0001493152-24-023541  Act: 33  Size: 1 MB 网页链接查看全文

增发股票注册声明「修订」

Abeona Therapeutics(ABEO)06-18 05:25

$Abeona Therapeutics(ABEO)$ S-3/A [Amend] Registration statement under Securities Act of 1933 Accession Number: 0001493152-24-024171  Act: 33  Size: 646 KB 网页链接查看全文

当期报告

Abeona Therapeutics(ABEO)07-10 04:35

$Abeona Therapeutics(ABEO)$ 8-K Current report, items 5.03 and 9.01 Accession Number: 0001493152-24-026640  Act: 34  Size: 362 KB 网页链接查看全文

持股变动声明

Abeona Therapeutics(ABEO)07-10 04:45

$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-026648  Size: 5 KB 网页链接查看全文

持股变动声明

Abeona Therapeutics(ABEO)07-10 04:45

$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-026641  Size: 4 KB 网页链接查看全文

当期报告

Abeona Therapeutics(ABEO)05-04 05:25

$Abeona Therapeutics(ABEO)$ 8-K Current report, items 1.01, 8.01, and 9.01 Accession Number: 0001493152-24-017768  Act: 34  Size: 1 MB 网页链接查看全文

Takeabreak2019-02-22 16:50

$Abeona Therapeutics(ABEO)$ It looks very cheap. Lesson learned cheap can get cheaper.查看全文

牛唐2019-02-15 14:15

$Krystal Biotech(KRYS)$ 在EB方面成药的可能性最大，$Abeona Therapeutics(ABEO)$ 之前数据好，但进度有延期，$Fibrocell Science(FCSC)$ 成药了估计也难卖，也就是资本市场炒一下查看全文

群氓鄙陋2018-12-11 04:46

$Abeona Therapeutics(ABEO)$ 三连阳哦，有潜力？查看全文

Takeabreak2018-11-19 21:15

$Abeona Therapeutics Inc.(ABEO)$ FT文章 titled "Gene Editing: careless Crispr."查看全文

Travis_ZZZ2018-11-12 23:07

$Abeona Therapeutics Inc.(ABEO)$ 完蛋查看全文

Pharmayang2018-11-02 08:40

$Abeona Therapeutics Inc.(ABEO)$ 仔细分析了一下。9块钱还是一个fair value。有兴趣的同学可以看看最近写的一个分析。谢谢大家。
网页链接查看全文

Colin_Lau2018-10-05 13:07

$Abeona Therapeutics Inc.(ABEO)$ MOX看空ABEO，目标价4-6美元。网页链接查看全文

Takeabreak2018-09-23 15:42

$Abeona Therapeutics Inc.(ABEO)$ 开始有点焦虑了，尤其是看着krys。手贱12.7又加了一点点。想着是不是搞些krys对冲一下查看全文

usbiostock2018-08-17 06:19

$Abeona Therapeutics Inc.(ABEO)$ EB-101治疗隐性营养不良型大疱性表皮松解症（RDEB）临床3期试验（VITAL研究）正式在clinicaltrials官网上线，该试验预计招募15名患者。临床试验号：NCT03632265查看全文

Takeabreak2018-08-15 13:18

$Abeona Therapeutics Inc.(ABEO)$ Largest shareholders include FMR LLC / Fidelity, Price T Rowe Associates Inc /md/, State Street Corp, Viking Global Investors LP, Wellington Management Group LLP, Knoll Capital Management, LP, Adage Capital Partners GP LLC, BlackRock Inc., Bak...查看全文

Abeona Therapeutics(ABEO.US)基因校正表皮获FDA优先审评资格

智通财经APP获悉，11月27日，Abeona Therapeutics(ABEO.US)宣布，美国FDA已接受其在研疗法pz-cel(prademagene zamikeracel，EB-101)的生物制品许可申请(BLA)，并授予优先审评资格，该疗法是一款自体、COL7A1基因校正表皮片，用于隐性... 网页链接

持股变动声明

$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-026645  Size: 4 KB 网页链接

持股变动声明

$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-026641  Size: 4 KB 网页链接

持股变动声明

$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-026644  Size: 4 KB 网页链接

持股变动声明

$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-026642  Size: 5 KB 网页链接

持股变动声明

$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-026643  Size: 4 KB 网页链接

持股变动声明

$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-026646  Size: 5 KB 网页链接

持股变动声明

$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-026647  Size: 5 KB 网页链接

持股变动声明

$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-026649  Size: 5 KB 网页链接

持股变动声明

$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-026648  Size: 5 KB 网页链接

当期报告

$Abeona Therapeutics(ABEO)$ 8-K Current report, items 5.03 and 9.01 Accession Number: 0001493152-24-026640  Act: 34  Size: 362 KB 网页链接